30-Day Mortality of Palliative Shunt Surgery for Cyanotic Congenital Heart Disease at Maharat Nakhon Ratchasima Hospital

Teera Hemrungrote; Damri Sethachinda; Rach Pongseeda

doi:10.64387/tjs.2025.271881

Authors

Teera Hemrungrote Department of Surgery, Maharat Nakhon Ratchasima Hospital
Damri Sethachinda Department of Surgery, Maharat Nakhon Ratchasima Hospital
Rach Pongseeda Department of Surgery, Maharat Nakhon Ratchasima Hospital

DOI:

https://doi.org/10.64387/tjs.2025.271881

Keywords:

Palliative shunt surgery, Modified Blalock-Taussig-Thomas shunt, Modified Waterston shunt, Central shunt, Modified Pott’s shunt

Abstract

Background: Palliative shunt surgery in pediatric patients with cyanotic conditions is complex and challenging. Corrective surgery is necessary for patients with reduced pulmonary blood oxygenation to address these abnormalities. Following surgery, patients demonstrate an improved survival rate. However, this operation has a considerable mortality compared to the survival benefit.

Patients and Methods: This study is a retrospective analysis collecting data on pediatric patients with cyanotic conditions who underwent palliative shunt surgery between January 1, 2020, and January 1, 2023. The patients were categorized into 4 procedural groups: Group 1, patients who underwent the modified Blalock-Taussig-Thomas shunt; Group 2, those who received the modified Waterston shunt; Group 3, patients with the central shunt; and Group 4, those who had the modified Pott’s shunt, respectively.

Results: A total of 86 pediatric patients with cyanotic congenital heart conditions underwent palliative shunt surgery, primarily closed-heart procedures. Nearly three-quarters of the patients (65 cases, 75.5%) were between 1 day and 1 year old. The modified Blalock-Taussig-Thomas shunt was the most common procedure performed in 56 patients (65.1%). Postoperative blood oxygen levels showed a statistically significant increase compared to preoperative levels in both the modified Blalock-Taussig-Thomas shunt and modified Waterston shunt procedures. Among the 56 patients who underwent the modified Blalock-Taussig-Thomas shunt, the 30-day mortality rate was 3.6%. For the modified Waterston shunt performed on 24 patients, the 30-day mortality rate was 12.5%. The Central shunt procedure was performed on 5 patients, with a 30-day mortality rate of 4 cases (80%). Overall, the 30-day mortality rate across all 86 cyanotic congenital heart disease patients undergoing palliative shunt surgery was 10.5%.

Conclusion: Four palliative shunt procedures are closed-heart surgeries intended as interim measures before major corrective surgery to address intracardiac abnormalities. Following the corrective surgeries, postoperative blood oxygen levels were higher than preoperative levels.

References

Lertsapcharoen P, Benjacholmas W. Congenital heart disease (in Thai). Bangkok: Sukhumvit Printing, 2011.

Alkhulaifi AM, Lacour-Gayet F, Serraf A, et al. Systemic pulmonary shunts in neonates: early clinical outcome and choice of surgical approach. Ann Thorac Surg. 2000;69(5):1499-504. doi: 10.1016/s0003-4975(00)01078-x.

de Leval MR, McKay R, Jones M, et al. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg. 1981;81(1):112-9.

Kiran U, Aggarwal S, Choudhary A, et al. The blalock and taussig shunt revisited. Ann Card Anaesth. 2017;20(3):323-30. doi: 10.4103/aca.ACA_80_17.

Tsai KT, Chang CH, Lin PJ. Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome. J Cardiovasc Surg (Torino). 1996;37(2):149-52.

Wells WJ, Logue WJ, Lindesmith GG. Modified Blalock-Taussig shunt in the neonate: factors influencing shunt failure. Circulation 1991;84(Suppl 2):II241.

Wells WJ, Yu RJ, Batra AS, et al. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg. 2005;79(6):2072-6. doi: 10.1016/j.athoracsur.2004.12.050.

Williams JA, Bansal AK, Kim BJ, et al. Two thousand Blalock-Taussig shunts: a six-decade experience. Ann Thorac Surg. 2007;84(6):2070-5; discussion 2070-5. doi: 10.1016/j.athoracsur.2007.06.067.

Lamberti JJ, Carlisle J, Waldman JD, et al. Systemic-pulmonary shunts in infants and children. Early and late results. J Thorac Cardiovasc Surg. 1984;88(1):76-81.

Fermanis GG, Ekangaki AK, Salmon AP, et al. Twelve year experience with the modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg. 1992;6(11):586-9. doi: 10.1016/1010-7940(92)90131-g.

Vitanova K, Leopold C, von Ohain JP, et al. Reasons for Failure of Systemic-to-Pulmonary Artery Shunts in Neonates. Thorac Cardiovasc Surg. 2019;67(1):2-7. doi: 10.1055/s-0037-1621706.

Soo KW, Brink J, d'Udekem Y, et al. Major Adverse Events Following Over-Shunting Are Associated With Worse Outcomes Than Major Adverse Events After a Blocked Systemic-to-Pulmonary Artery Shunt Procedure. Pediatr Crit Care Med. 2018;19(9):854-60. doi: 10.1097/PCC.0000000000001659.

Ismail SR, Almazmi MM, Khokhar R, et al. Effects of protocol-based management on the post-operative outcome after systemic to pulmonary shunt. Egypt Heart J. 2018;70(4):271-8. doi: 10.1016/j.ehj.2018.09.007.